Rogers Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
Week In Review: Bio-Thera Raises $241 Million In Shanghai STAR IPO For Antibody Portfolio
Article By: ChinaBio® Today Saturday, February 15, 2020 4:19 PM EDT
Bio-Thera Solutions of Guangzhou priced its IPO on Shanghai’s STAR Board to raise $241 million at a valuation of almost $2 billion. The offering, which placed 60 million shares at RMB32.76 each, was reported to be 3,225 times oversubscribed.
In this article: JNJ, ROG, GILD, ZLAB
Week In Review: Sorrento Therapeutics Fights $933 Million Take-Private Bid
Article By: ChinaBio® Today Saturday, February 1, 2020 5:24 PM EDT
Sorrento Therapeutics, a San Diego-Nanjing-Suzhou biopharma, rejected a $7 per share take-private offer from an unnamed PE company that valued the company at $933 million. Sorrento reported a loss of $57 million over the last 12 months.
In this article: AZN, ROG, SRNE, DMPI, EYPT
Week In Review: South Korea's Celltrion Plans $513 Million Biologics Facility In Wuhan
Article By: ChinaBio® Today Saturday, January 25, 2020 4:50 PM EDT
Celltrion, a South Korea biopharma, plans to build a $513 million China biologics manufacturing facility in Wuhan. The company said the plant's 120,000 liter capacity will make it the largest facility in China.
In this article: ROG, ZLAB
Avoid These Overvalued Momentum Stocks
Article By: David Trainer Wednesday, May 8, 2019 9:47 AM EDT
These stocks are some of the best performing so far in 2019, but they have misleading earnings and significant downside risk.
In this article: ROG, CVNA
Week In Review: Hansoh Plans Hong Kong IPO To Raise Up To $1 Billion
Article By: ChinaBio® Today Saturday, April 13, 2019 4:09 PM EDT
Hansoh Pharma, an established drug company, has filed for a Hong Kong IPO, and is rumored to seek between $500 million and $1 billion in new capital. It's a profitable drug company with $1.1 billion in revenue and more than $280 million in profits.
In this article: ROG, BGNE, BAYN, BAYN
Week In Review: Jiangsu Hansoh To Raise Up To $3 Billion In Hong Kong IPO
Article By: ChinaBio® Today Saturday, September 8, 2018 4:22 PM EDT
Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange. Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established.
In this article: GSK, LLY, BGNE, ZLAB, ROG, HCM, MRK
Week In Review: James Watson To Lead New Shenzhen Biopharma Research Center
Article By: ChinaBio® Today Saturday, March 24, 2018 5:53 PM EDT
James Watson, who co-discovered the double-helix structure of DNA in 1953, will lead a new international life science research center in the International Bio Valley, located in Shenzhen's Dapeng New Area.
In this article: ROG, AVH, NVS, CASI, CBMG, DOVA
5 Terrific Small Caps - Monday, Dec. 18
Article By: Jim Van Meerten Monday, December 18, 2017 12:40 PM EDT
Today's watch-list includes: Lending Tree, Nektar Therapeutics, Solaredge Technologies, LGI Homes and Rogers.
In this article: ROG, TREE, NKTR, LGIH, SEDG
1 to 8 of 8 Posts